Tuesday, 13 October 2009

Rhophylac


Generic Name: RHo (D) immune globulin (ROE D im MYOON GLOB yoo lin)

Brand Names: HyperRHO S/D Full Dose, HyperRHO S/D Mini Dose, MicRhoGAM Ultra-Filtered Plus, RhoGAM Ultra-Filtered Plus, Rhophylac, WinRho SDF


What is RHo (D) immune globulin?

RHo (D) immune globulin is a sterilized solution made from human blood. Rh is a substance that most people have in their blood (Rh positive) but some people don't (Rh negative). A person who is Rh negative can be exposed to Rh positive blood through a mismatched blood transfusion or during pregnancy when the baby has the opposite blood type. When this exposure happens, the Rh negative blood will respond by making antibodies that will try to destroy the Rh positive blood cells. This can cause medical problems such as anemia (loss of red blood cells), kidney failure, or shock.


RHo (D) immune globulin is used to prevent an immune response to Rh positive blood in people with an Rh negative blood type. RHo (D) immune globulin may also be used in the treatment of immune thrombocytopenic purpura (ITP).


RHo (D) immune globulin may also be used for purposes not listed in this medication guide.


What is the most important information I should know about RHo (D) immune globulin?


You should not receive this medication if you have ever had an allergic reaction to an immune globulin or if you have immune globulin A (IgA) deficiency with antibody to IgA. You should not receive RHo (D) immune globulin if you have hemolytic anemia (a lack of red blood cells).

Before you receive this medication, tell your doctor if you have heart disease or a history of coronary artery disease, high triglycerides, a bleeding disorder, or immune globulin A (IgA) deficiency.


If you are an Rh-negative woman and you become pregnant, you must tell your doctor if you have ever been exposed to Rh-positive blood in your lifetime. This includes exposure from a mismatched blood transfusion, or exposure during your first pregnancy. Your history of exposure and treatment will be extremely important to each and every one of your pregnancies.


Call your doctor at once if you have a serious side effect such as fever, chills, shaking, back pain, dark colored urine, rapid breathing, feeling short of breath, urinating less than usual, swelling, rapid weight gain, pale skin, easy bruising or bleeding, rapid heart rate, trouble concentrating, feeling light-headed. Do not receive a "live" vaccine for at least 3 months after treatment with RHo (D) immune globulin. The vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), Bacillus Calmette-Guérin (BCG), oral polio, rotavirus, smallpox, typhoid, yellow fever, varicella (chickenpox), H1N1 influenza, and nasal flu vaccine.

What should I discuss with my healthcare provider before I receive RHo (D) immune globulin?


You should not receive this medication if you have ever had an allergic reaction to an immune globulin or if you have immune globulin A (IgA) deficiency with antibody to IgA. You should not receive RHo (D) immune globulin if you have hemolytic anemia (a lack of red blood cells).

To make sure you can safely receive RHo (D) immune globulin, tell your doctor if you have any of these other conditions:



  • heart disease or a history of coronary artery disease (hardened arteries);




  • high triglycerides (a type of fat in the blood);




  • a bleeding disorder (such as hemophilia); or




  • immune globulin A (IgA) deficiency.



RHo (D) immune globulin is used during and after pregnancy. This medication is not known to be harmful to a baby during pregnancy or while breast-feeding.


If you are receiving this medication to treat a mismatched blood transfusion, tell your doctor if you are pregnant or if you ever plan to become pregnant.


If you are an Rh-negative woman and you become pregnant, you must tell your doctor if you have ever been exposed to Rh-positive blood in your lifetime. This includes exposure from a mismatched blood transfusion, or exposure during your first pregnancy. Your history of exposure and treatment will be extremely important to each and every one of your pregnancies.


RHo (D) immune globulin is made from human plasma (part of the blood) which may contain viruses and other infectious agents. Donated plasma is tested and treated to reduce the risk of it containing infectious agents, but there is still a small possibility it could transmit disease. Talk with your doctor about the risks and benefits of using this medication.

How is RHo (D) immune globulin given?


RHo (D) immune globulin is injected into a muscle or a vein. You will receive this injection in a clinic or hospital setting.


Your breathing, blood pressure, oxygen levels, and other vital signs will be watched closely for at least 8 hours after you receive immune globulin. Your urine will also need to be tested every 2 to 4 hours.

For treatment during pregnancy, this medication is usually given at regular intervals during the last half of the pregnancy, and again after the baby is born.


For treatment of a mismatched blood transfusion, the medication is given when symptoms of an immune response appear (when the body starts making Rh antibodies).


To be sure this medicine is helping your condition, your blood will need to be tested often. Your liver and kidney function may also need to be tested. Visit your doctor regularly.


This medication can cause false results with certain lab tests for glucose (sugar) in the blood. Tell any doctor who treats you that you are using RHo (D) immune globulin.

What happens if I miss a dose?


Call your doctor for instructions if you miss an appointment for your RHo (D) immune globulin injection.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while receiving RHo (D) immune globulin?


Do not receive a "live" vaccine for at least 3 months after treatment with RHo (D) immune globulin. The vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), Bacillus Calmette-Guérin (BCG), oral polio, rotavirus, smallpox, typhoid, yellow fever, varicella (chickenpox), H1N1 influenza, and nasal flu vaccine.

RHo (D) immune globulin side effects


Get emergency medical help if you have any of these signs of an allergic reaction: rash or hives; feeling light-headed, chest tightness, difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:

  • fever, chills, shaking, back pain, dark colored urine;




  • rapid breathing, feeling short of breath.




  • urinating less than usual or not at all, swelling, rapid weight gain; or




  • pale skin, easy bruising or bleeding, rapid heart rate, trouble concentrating, feeling light-headed.



Less serious side effects may include:



  • joint or muscle pain;




  • headache, dizziness;




  • feeling weak or tired;




  • mild itching or skin rash;




  • nausea, diarrhea, vomiting, stomach pain; or




  • pain or tenderness where the medicine was injected.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect RHo (D) immune globulin?


There may be other drugs that can interact with RHo (D) immune globulin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Rhophylac resources


  • Rhophylac Side Effects (in more detail)
  • Rhophylac Use in Pregnancy & Breastfeeding
  • Rhophylac Drug Interactions
  • Rhophylac Support Group
  • 0 Reviews for Rhophylac - Add your own review/rating


  • Rhophylac Prescribing Information (FDA)

  • Rhophylac Consumer Overview

  • Rhophylac Advanced Consumer (Micromedex) - Includes Dosage Information

  • Rhophylac MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bayrho-D full dose

  • HyperRHO S/D Full Dose Prescribing Information (FDA)

  • MICRhoGAM MedFacts Consumer Leaflet (Wolters Kluwer)

  • RhoGAM Ultra-Filtered PLUS Prescribing Information (FDA)

  • WinRho SDF MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Rhophylac with other medications


  • Idiopathic Thrombocytopenic Purpura
  • Rh-Isoimmunization


Where can I get more information?


  • Your doctor or pharmacist can provide more information about RHo (D) immune globulin.

See also: Rhophylac side effects (in more detail)


Oxsoralen-Ultra


Generic Name: methoxsalen (Oral route)

meth-OX-a-len

Oral route(Capsule)

Methoxsalen with UV radiation should be used only by physicians who have special competence in diagnosis and treatment of psoriasis and who have special training and experience in photochemotherapy. Photochemotherapy should be restricted to patients with severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy. Risks of therapy include ocular damage, aging of the skin, and skin cancer (including melanoma). The soft gelatin capsules should not be used interchangeably with regular methoxsalen hard gelatin capsules due to greater bioavailability and earlier photosensitization onset time .



Commonly used brand name(s)

In the U.S.


  • 8-Mop

  • Oxsoralen-Ultra

Available Dosage Forms:


  • Capsule

Therapeutic Class: Antipsoriatic


Chemical Class: Psoralen


Uses For Oxsoralen-Ultra


Methoxsalen belongs to the group of medicines called psoralens. It is used along with ultraviolet light (found in sunlight and some special lamps) in a treatment called PUVA to treat vitiligo, a disease in which skin color is lost, and psoriasis, a skin condition associated with red and scaly patches.


Methoxsalen is also used with ultraviolet light in the treatment of white blood cells. This treatment is called photopheresis and is used to treat the skin problems associated with mycosis fungoides, which is a type of lymphoma.


Methoxsalen may also be used for other conditions as determined by your doctor.


This medicine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in the product labeling, methoxsalen is used in certain patients with the following medical conditions:


  • Alopecia areata

  • Atopic dermatitis

  • Eczema

  • Lichen planus

  • Skin that is abnormally sensitive to sunlight

Before Using Oxsoralen-Ultra


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Methoxsalen is a very strong medicine that increases the skin's sensitivity to sunlight. In addition to causing serious sunburns if not properly used, it has been reported to increase the chance of skin cancer and cataracts. Also, like too much sunlight, PUVA can cause premature aging of the skin. Therefore, methoxsalen should be used only as directed and it should not be used simply for suntanning. Before using this medicine, be sure that you have discussed its use with your doctor.


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Some of the side effects are more likely to occur in children up to 12 years of age, since these children may be more sensitive to the effects of methoxsalen.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of methoxsalen in the elderly with use in other age groups.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Phenytoin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergy to sunlight (or family history of) or

  • Infection or

  • Lupus erythematosus or

  • Porphyria or

  • Skin cancer (history of) or

  • Skin conditions (other) or

  • Stomach problems—Use of PUVA may make the condition worse

  • Eye problems, such as cataracts or loss of the lens of the eye—The light treatment may make the condition worse or may cause damage to the eye

  • Heart or blood vessel disease (severe)—The heat or prolonged standing associated with each light treatment may make the condition worse

  • Liver disease—Condition may cause increased blood levels of the medicine and cause an increase in side effects

Proper Use of methoxsalen

This section provides information on the proper use of a number of products that contain methoxsalen. It may not be specific to Oxsoralen-Ultra. Please read with care.


Eating certain foods while you are taking methoxsalen may increase your skin's sensitivity to sunlight. To help prevent this, avoid eating limes, figs, parsley, parsnips, mustard, carrots, and celery while you are being treated with this medicine.


Methoxsalen usually comes with patient directions. Read them carefully before using this medicine.


This medicine may take 6 to 8 weeks to really help your condition. Do not increase the amount of methoxsalen you are taking or spend extra time in the sunlight or under an ultraviolet lamp. This will not make the medicine act any more quickly and may result in a serious burn.


If this medicine upsets your stomach:


  • Patients taking the hard gelatin capsules may take them with food or milk.

  • Patients taking the soft gelatin capsules may take them with low-fat food or low-fat milk.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (hard gelatin capsule):
    • For treating mycosis fungoides and psoriasis:
      • Adults and children 12 years of age and over—Dose is based on body weight and must be determined by your doctor. However, the usual dose is 0.6 mg per kilogram (kg) (0.27 mg per pound) of body weight taken two hours before UVA exposure. This treatment (methoxsalen and UVA) is given two or three times a week with the treatment spaced at least forty-eight hours apart.

      • Children up to 12 years of age—Dose must be determined by your doctor.


    • For vitiligo:
      • Adults and children 12 years of age and over—20 milligrams (mg) per day taken two to four hours before ultraviolet light A (UVA) exposure. This treatment (methoxsalen and UVA) is given two or three times a week with the treatment spaced at least forty-eight hours apart.

      • Children up to 12 years of age—Dose must be determined by your doctor.



  • For oral dosage form (soft gelatin capsule):
    • For psoriasis:
      • Adults and children 12 years of age and over—Dose is based on body weight and must be determined by your doctor. The usual dose is 0.4 mg per kg (0.18 mg per pound) of body weight taken one and one-half to two hours before UVA exposure. This treatment (methoxsalen and UVA) is given two or three times a week, with the treatment spaced at least forty-eight hours apart.

      • Children up to 12 years of age—Dose must be determined by your doctor.



Missed Dose


Call your doctor or pharmacist for instructions.


If you are late in taking, or miss taking, a dose of this medicine, notify your doctor so your light treatment can be rescheduled. Remember that exposure to sunlight or ultraviolet light must take place a certain number of hours after you take the medicine or it will not work. For patients taking the hard gelatin capsules, this is 2 to 4 hours. For patients taking the soft gelatin capsules, this is 1½ to 2 hours. If you have any questions about this, check with your doctor.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Oxsoralen-Ultra


Your doctor should check your progress at regular visits to make sure this medicine is working and that it does not cause unwanted effects. Eye examinations should be included.


This medicine increases the sensitivity of your skin and lips to sunlight. Therefore, exposure to the sun, even through window glass or on a cloudy day, could cause a serious burn. If you must go out during the daylight hours:


  • Before each treatment, cover your skin for at least 24 hours by wearing protective clothing, such as long-sleeved shirts, full-length slacks, wide-brimmed hat, and gloves. In addition, protect your lips with a special sun block lipstick that has a skin protection factor (SPF) of at least 15. Check with your doctor before using sun block products on other parts of your body before a treatment, since sun block products should not be used on the areas of your skin that are to be treated.

  • After each treatment, cover your skin for at least 8 hours by wearing protective clothing. In addition, use a sun block product that has a skin protection factor (SPF) of at least 15 on your lips and on those areas of your body that cannot be covered.

If you have any questions about this, check with your health care professional.


Your skin may continue to be sensitive to sunlight for some time after treatment with this medicine. Use extra caution for at least 48 hours following each treatment if you plan to spend any time in the sun. In addition, do not sunbathe anytime during your course of treatment with methoxsalen.


For 24 hours after you take each dose of methoxsalen, your eyes should be protected during daylight hours with special wraparound sunglasses that totally block or absorb ultraviolet light (ordinary sunglasses are not adequate). This is to prevent cataracts. Your doctor will tell you what kind of sunglasses to use. These glasses should be worn even in indirect light, such as light coming through window glass or on a cloudy day.


This medicine may cause your skin to become dry or itchy. However, check with your doctor before applying anything to your skin to treat this problem.


Oxsoralen-Ultra Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


  • Blistering and peeling of skin

  • reddened, sore skin

  • swelling (especially of feet or lower legs)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Itching of skin

  • nausea

Less common
  • Dizziness

  • headache

  • mental depression

  • nervousness

  • trouble in sleeping

Treatment with this medicine usually causes a slight reddening of your skin 24 to 48 hours after the treatment. This is an expected effect and is no cause for concern. However, check with your doctor right away if your skin becomes sore and red or blistered.


There is an increased risk of developing skin cancer after use of methoxsalen. You should check your body regularly and show your doctor any skin sores that do not heal, new skin growths, and skin growths that have changed in the way they look or feel.


Premature aging of the skin may occur as a result of prolonged methoxsalen therapy. This effect is permanent and is similar to what happens when a person sunbathes for long periods of time.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Oxsoralen-Ultra side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Oxsoralen-Ultra resources


  • Oxsoralen-Ultra Side Effects (in more detail)
  • Oxsoralen-Ultra Use in Pregnancy & Breastfeeding
  • Drug Images
  • Oxsoralen-Ultra Drug Interactions
  • Oxsoralen-Ultra Support Group
  • 0 Reviews for Oxsoralen-Ultra - Add your own review/rating


  • Oxsoralen-Ultra Concise Consumer Information (Cerner Multum)

  • Oxsoralen-Ultra Soft-Gelatin Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Oxsoralen-Ultra Prescribing Information (FDA)

  • Methoxsalen Professional Patient Advice (Wolters Kluwer)

  • 8-MOP Prescribing Information (FDA)

  • 8-MOP Hard-Gelatin Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Uvadex Prescribing Information (FDA)



Compare Oxsoralen-Ultra with other medications


  • Psoriasis

Monday, 12 October 2009

Telbans DS




Telbans DS may be available in the countries listed below.


Ingredient matches for Telbans DS



Theophylline

Theophylline is reported as an ingredient of Telbans DS in the following countries:


  • Japan

International Drug Name Search

Sunday, 11 October 2009

Prednisolone Sodium Succinate




Prednisolone Sodium Succinate may be available in the countries listed below.


Ingredient matches for Prednisolone Sodium Succinate



Prednisolone

Prednisolone Sodium Succinate (USAN) is known as Prednisolone in the US.

International Drug Name Search

Glossary

USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 5 October 2009

Balgin




Balgin may be available in the countries listed below.


Ingredient matches for Balgin



Dimeticone

Dimeticone is reported as an ingredient of Balgin in the following countries:


  • Japan

Sodium Bicarbonate

Sodium Bicarbonate is reported as an ingredient of Balgin in the following countries:


  • Japan

International Drug Name Search

Sunday, 4 October 2009

Rani 2




Rani 2 may be available in the countries listed below.


Ingredient matches for Rani 2



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Rani 2 in the following countries:


  • Australia

International Drug Name Search

Saturday, 26 September 2009

Bacsul Balsámico




Bacsul Balsámico may be available in the countries listed below.


Ingredient matches for Bacsul Balsámico



Guaifenesin

Guaifenesin is reported as an ingredient of Bacsul Balsámico in the following countries:


  • Peru

Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Bacsul Balsámico in the following countries:


  • Peru

Trimethoprim

Trimethoprim is reported as an ingredient of Bacsul Balsámico in the following countries:


  • Peru

International Drug Name Search